Archive: November 2015

Moving Toward Targeted Therapies in Acute Myeloid Leukemia

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Weiqiang Gao, MD, PhD, and Elihu Estey, MD Dr Gao is a clinical fellow […]

Neoadjuvant Breast Cancer Therapy and Drug Development

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Patricia Cortazar, MD, and Paul G. Kluetz, MD The authors are affiliated with the […]

Immune Therapy in Multiple Myeloma

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Katarina Luptakova, MD, and David Avigan, MD Dr Luptakova is a hematologist-oncologist affiliated with […]

The Effect of ICD-10-CM Coding on Nonmalignant Hematology

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Andrew D. Boyd, MD Assistant Professor Biomedical and Health Information Sciences College of Applied […]

New Drugs in Development for Melanoma

Keith T. Flaherty, MD

  H&O What are the shortcomings of existing agents for melanoma? KF All of the new melanoma agents approved by the US Food and Drug Administration […]

Use of Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Chris Parker, MD Consultant in Clinical Oncology Royal Marsden Hospital Sutton, United Kingdom There […]

Should All Patients With SCLC Receive Prophylactic Cranial Irradiation If They Have Responded to Treatment?

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Ben J. Slotman, MD, PhD vs Jacob Yousef, BS, and Henry Wagner, MD Brain […]

Current Treatment Approaches in Follicular Lymphoma

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Brad S. Kahl, MD Professor of Medicine Washington University School of Medicine St Louis, […]

November Hem/Onc News

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Devon Schuyler FDA Approves Pembrolizumab for Metastatic NSCLC The US Food and Drug Administration […]

Letter From the Editor: For What It’s Worth

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 “There’s something happening here / What it is ain’t exactly clear.” —Stephen Stills Bruce […]

Back to Archive